Skip to content

Idiographic study of Neurofeedback to Ameliorate Mood in the Elderly (i-NAME); A pilot study with six patients.

Idiographic study of Neurofeedback to Ameliorate Mood in the Elderly (i-NAME); A pilot study with six patients. - i-NAME

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON43268
Enrollment
6
Registered
2016-05-26
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

depression major depressive disorder

Interventions

None listed

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age 60 years or over. - Suffering from clinically relevant depressive symptoms defined as a score of 16 or more on the Center for Epidemiological Studies Depression Scale (CES-D) (Radloff, 1977; Eaton et al, 2004). - Having met the criteria of Diagnostic and Statistical Manual of Mental Disorders (DSM-5) for a major depressive disorder (MDD) within the past 12 months (but no current MDD) as established with the Mini International Neuropsychiatric Interview (version 5.0). - Right handedness. - Giving informed consent after oral and written information about the study

Exclusion criteria

Exclusion criteria: - Insufficient command of the Dutch language. - Not capable of daily neurofeedback training. - Major psychiatric comorbidity other than an affective disorder (encompassing mood-, anxiety or somatoform disorders). - An established (or suspected) diagnosis of dementia or a neurodegenerative disorder.

Design outcomes

Primary

MeasureTime frame
Variance in depressive symptoms explained by changes in NF induced frontal alpha lateralization within individuals.

Secondary

MeasureTime frame
- Feasibility and patient burden of both NF training and data collection from a patient perspective - Compliance to NF training and study procedures - Psychopathology at baseline, and after 4, 8 and 12 weeks.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)